Modulation of mouse cardiac function in vivo by eNOS and ANP - PubMed (original) (raw)
Modulation of mouse cardiac function in vivo by eNOS and ANP
R Gyurko et al. Am J Physiol Heart Circ Physiol. 2000 Mar.
Free article
Abstract
To study the role of endothelial nitric oxide synthase (eNOS) in cardiac function, we compared eNOS expression, contractility, and relaxation in the left ventricles of wild-type and eNOS-deficient mice. eNOS immunostaining is localized to the macro- and microvascular endothelium throughout the myocardium in wild-type mice and is absent in eNOS-/- mice. Whereas blood pressure is elevated in eNOS-/- mice, baseline cardiac contractility (dP/dt(max)) is similar in wild-type and eNOS-/- mice (9,673 +/- 2, 447 and 9,928 +/- 1,566 mmHg/s, respectively). The beta-adrenergic agonist isoproterenol (Iso) at doses of >/=1 ng causes enhanced increases in dP/dt(max) in eNOS-/- mice compared with wild-type controls in vivo (P < 0.01) as well as in Langendorff isolated heart preparations (P < 0.02). beta-Adrenergic receptor binding (B(max)) is not significantly different in the two groups of animals (B(max) = 41.4 +/- 9.4 and 36.1 +/- 5.1 fmol/mg for wild-type and eNOS-/-). Iso-stimulated ventricular relaxation is also enhanced in the eNOS-/- mice, as measured by dP/dt(min) in the isolated heart. However, baseline ventricular relaxation is normal in eNOS-/- mice (tau = 5.2 +/- 1.0 and 5.6 +/- 1.5 ms for wild-type and eNOS-/-, respectively), whereas it is impaired in wild-type mice after NOS inhibition (tau = 8.3 +/- 2.4 ms). cGMP levels in the left ventricle are unaffected by eNOS gene deletion (wild-type: 3.1 +/- 0.8 pmol/mg, eNOS-/-: 3.1 +/- 0.6 pmol/mg), leading us to examine the level of another physiological regulator of cGMP. Atrial natriuretic peptide (ANP) expression is markedly upregulated in the eNOS-/- mice, and exogenous ANP restores ventricular relaxation in wild-type mice treated with NOS inhibitors. These results suggest that eNOS attenuates both inotropic and lusitropic responses to beta-adrenergic stimulation, and it also appears to regulate baseline ventricular relaxation in conjunction with ANP.
Similar articles
- Inotropic response to beta-adrenergic receptor stimulation and anti-adrenergic effect of ACh in endothelial NO synthase-deficient mouse hearts.
Gödecke A, Heinicke T, Kamkin A, Kiseleva I, Strasser RH, Decking UK, Stumpe T, Isenberg G, Schrader J. Gödecke A, et al. J Physiol. 2001 Apr 1;532(Pt 1):195-204. doi: 10.1111/j.1469-7793.2001.0195g.x. J Physiol. 2001. PMID: 11368026 Free PMC article. - Disruption of inducible nitric oxide synthase improves beta-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy.
Funakoshi H, Kubota T, Kawamura N, Machida Y, Feldman AM, Tsutsui H, Shimokawa H, Takeshita A. Funakoshi H, et al. Circ Res. 2002 May 17;90(9):959-65. doi: 10.1161/01.res.0000017632.83720.68. Circ Res. 2002. PMID: 12016261 - Muscarinic and beta-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase.
Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R. Vandecasteele G, et al. Nat Med. 1999 Mar;5(3):331-4. doi: 10.1038/6553. Nat Med. 1999. PMID: 10086391 - Modulation of cardiac contraction, relaxation and rate by the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice.
Massion PB, Balligand JL. Massion PB, et al. J Physiol. 2003 Jan 1;546(Pt 1):63-75. doi: 10.1113/jphysiol.2002.025973. J Physiol. 2003. PMID: 12509479 Free PMC article. Review. - Neuronal and endothelial nitric oxide synthase gene knockout mice.
Huang PL. Huang PL. Braz J Med Biol Res. 1999 Nov;32(11):1353-9. doi: 10.1590/s0100-879x1999001100005. Braz J Med Biol Res. 1999. PMID: 10559836 Review.
Cited by
- Pathological cardiac hypertrophy alters intracellular targeting of phosphodiesterase type 5 from nitric oxide synthase-3 to natriuretic peptide signaling.
Zhang M, Takimoto E, Lee DI, Santos CX, Nakamura T, Hsu S, Jiang A, Nagayama T, Bedja D, Yuan Y, Eaton P, Shah AM, Kass DA. Zhang M, et al. Circulation. 2012 Aug 21;126(8):942-51. doi: 10.1161/CIRCULATIONAHA.112.090977. Epub 2012 Jul 24. Circulation. 2012. PMID: 22829024 Free PMC article. - Prolonged Action Potential and After depolarizations Are Not due to Changes in Potassium Currents in NOS3 Knockout Ventricular Myocytes.
Wang H, Bonilla IM, Huang X, He Q, Kohr MJ, Carnes CA, Ziolo MT. Wang H, et al. J Signal Transduct. 2012;2012:645721. doi: 10.1155/2012/645721. Epub 2012 Aug 28. J Signal Transduct. 2012. PMID: 22970362 Free PMC article. - Nitric oxide synthases in heart failure.
Carnicer R, Crabtree MJ, Sivakumaran V, Casadei B, Kass DA. Carnicer R, et al. Antioxid Redox Signal. 2013 Mar 20;18(9):1078-99. doi: 10.1089/ars.2012.4824. Epub 2012 Sep 20. Antioxid Redox Signal. 2013. PMID: 22871241 Free PMC article. Review. - IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function.
Abston ED, Barin JG, Cihakova D, Bucek A, Coronado MJ, Brandt JE, Bedja D, Kim JB, Georgakopoulos D, Gabrielson KL, Mitzner W, Fairweather D. Abston ED, et al. Circ Heart Fail. 2012 May 1;5(3):366-75. doi: 10.1161/CIRCHEARTFAILURE.111.963769. Epub 2012 Mar 27. Circ Heart Fail. 2012. PMID: 22454393 Free PMC article. - Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.
Wang H, Kohr MJ, Traynham CJ, Ziolo MT. Wang H, et al. J Mol Cell Cardiol. 2009 Aug;47(2):304-14. doi: 10.1016/j.yjmcc.2009.03.021. Epub 2009 Apr 1. J Mol Cell Cardiol. 2009. PMID: 19345227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases